Introduction

In 2026, the world is once again watching an Ebola outbreak unfold in Central Africa. This time, the disease is caused by the Bundibugyo virus, one of the lesser-known members of the Ebola virus family. Health authorities have reported thousands of confirmed infections, making it one of the fastest-growing Ebola outbreaks ever recorded. Unlike previous outbreaks caused by the Zaire species of Ebola virus, there is currently no licensed vaccine or approved targeted treatment specifically for the Bundibugyo virus, making containment even more challenging. (Read more) (Read more)

For many people, the word Ebola immediately brings to mind terrifying images of bleeding patients dressed in protective suits. Yet that picture tells only a small part of the story. What makes Ebola so frightening is not simply that it can cause severe illness. It is the remarkable way this virus invades the body, evades the immune system, damages blood vessels, and triggers a cascade of events that can lead to multiple organ failure. At the same time, not every infected person dies. Some recover completely, while others carry traces of the virus in certain parts of their body for months after they feel healthy again.

These mysteries have fascinated scientists since Ebola was first identified in 1976. Nearly fifty years later, researchers understand far more about the virus, yet many questions remain unanswered. This article is not about following daily case numbers. Instead, it explores the science behind one of humanity’s most feared viruses and explains why Ebola behaves so differently from most other infectious diseases.

---

Featured Snippet

Ebola is one of the deadliest viral diseases because it attacks immune cells, disrupts blood vessels, and triggers widespread inflammation that can lead to organ failure. Yet not every patient experiences severe bleeding, and some survive because of differences in immune responses, medical care, and the amount of virus they are exposed to.

---

A Tiny Virus With Devastating Power

At first glance, Ebola does not look particularly intimidating.

Under an electron microscope, it appears as a long, thread-like filament, often curled into the shape of a shepherd’s crook or the number six. Each virus particle measures only about 80 nanometres wide, roughly one-thousandth the width of a human hair. Yet inside this microscopic thread lies genetic information capable of overwhelming one of the most sophisticated immune systems in nature.

Ebola belongs to the Filoviridae family, a group of filament-shaped viruses. Scientists have identified several Ebola virus species, including Zaire, Sudan, Bundibugyo, Taï Forest, Reston, and Bombali. While all belong to the same viral family, they do not all affect humans in the same way.

The current outbreak involves the Bundibugyo virus, which generally causes a lower fatality rate than the Zaire species but remains a serious public health threat because no licensed vaccine currently exists specifically against it.

Why Doesn’t the Virus Kill Immediately?

Unlike snake venom or certain bacterial toxins, Ebola does not kill by releasing a powerful poison.

Instead, it turns your own body against itself. After entering the body through broken skin or mucous membranes, the virus begins searching for some of the immune system’s first responders: macrophages and dendritic cells. These cells normally patrol the body looking for dangerous microbes. Their job is to detect an invader, sound the alarm, and activate the rest of the immune system.

Ebola exploits this very defense system. Once inside these immune cells, the virus hijacks their molecular machinery to make thousands of copies of itself. Instead of acting as defenders, infected immune cells become virus-producing factories. Even worse, these cells travel throughout the body, carrying the virus to the liver, spleen, lymph nodes, adrenal glands, and many other organs. The body’s own security guards unknowingly become vehicles for viral spread.

🧠 ScienceBuzzer Insight

Ebola is a master of deception.

Most viruses try to hide from the immune system. Ebola goes one step further. It infects the very cells that are supposed to coordinate the body’s defenses, turning them into unwitting carriers that spread the virus throughout the body before the immune system can mount an effective response.

---

How Ebola Outsmarts the Immune System

One reason Ebola is so dangerous is that it launches a two-pronged attack.

First, it multiplies rapidly. Second, it prevents the immune system from communicating effectively. Healthy cells normally release proteins called interferons, which act like emergency broadcasts warning neighboring cells about viral invasion. Ebola produces proteins that interfere with these warning signals. As a result, infected cells continue producing viruses while nearby cells remain largely unaware of the danger. Meanwhile, infected immune cells begin releasing enormous quantities of inflammatory molecules known as cytokines. Under normal circumstances, cytokines help coordinate the immune response. During severe Ebola infection, however, this response becomes uncontrolled. Scientists often describe this phenomenon as a cytokine storm, where the immune system’s attempt to eliminate the virus ends up damaging the body’s own tissues. Imagine firefighters trying to extinguish a small kitchen fire by flooding an entire neighborhood. The original problem is real, but the response becomes so overwhelming that it causes widespread destruction.

That is precisely what happens inside many patients with severe Ebola disease.

Why Do Some People Die While Others Survive?

This is one of the biggest unanswered questions in Ebola research.

Scientists know that survival depends on several interacting factors rather than a single cause. One important factor is how quickly the immune system responds. People who mount an early, well-coordinated immune response are more likely to control viral replication before it reaches extremely high levels. The amount of virus entering the body, known as the infectious dose, may also influence disease severity. Healthcare workers exposed without adequate protection or family members caring for severely ill patients can receive a much larger viral exposure than someone with brief accidental contact.

Age, underlying health conditions, nutritional status, and access to supportive medical care also play major roles. Modern treatment centers equipped with intravenous fluids, electrolyte replacement, oxygen therapy, and intensive monitoring have significantly improved survival compared with earlier outbreaks. (read more)

Yet even among patients receiving similar care, outcomes can differ dramatically. Researchers suspect that genetic differences in human immune responses may partly explain why some people recover while others develop life-threatening disease. This remains an active area of scientific investigation.

Why Do Ebola Patients Bleed? The Truth Is More Complicated

Perhaps no symptom has shaped Ebola’s terrifying reputation more than bleeding. News reports often describe Ebola as a “hemorrhagic fever,” leading many people to believe that every patient bleeds profusely.

That is not true.

In fact, many Ebola patients never develop dramatic external bleeding. Fever, vomiting, severe diarrhea, weakness, dehydration, and shock are far more common. Bleeding, when it occurs, usually appears later in severe disease and affects only a proportion of patients.

So why does Ebola have this reputation? The answer lies in how the virus disrupts the body’s delicate balance between inflammation, blood clotting, and blood vessel integrity. As the infection spreads, inflammatory chemicals damage the cells lining blood vessels, making them unusually leaky. At the same time, Ebola interferes with the liver’s ability to produce clotting factors while also triggering widespread activation of the clotting system.

Doctors call this condition disseminated intravascular coagulation (DIC). Tiny blood clots begin forming throughout the body, consuming platelets and clotting proteins. Eventually, the body’s supply of these essential components becomes exhausted. When bleeding finally occurs, the body struggles to stop it. Patients may experience bleeding from the gums, nose, injection sites, or digestive tract, but the hallmark of severe Ebola is often circulatory collapse, not dramatic blood loss.

---

🧠 ScienceBuzzer Insight

The biggest danger is often dehydration, not bleeding.

Severe vomiting and diarrhea can cause patients to lose enormous amounts of fluid and electrolytes within a short time. Modern Ebola treatment focuses heavily on aggressive fluid replacement, electrolyte correction, and supportive intensive care, which have substantially improved survival during recent outbreaks.

---

When the Body Begins to Shut Down

As Ebola spreads, several vital organs become infected. The liver is one of its major targets. The liver performs hundreds of essential functions, including producing proteins that help blood clot, regulating metabolism, detoxifying harmful substances, and supporting immune responses. When liver cells become infected, these functions begin to fail. The kidneys also suffer. Low blood pressure, dehydration, inflammation, and direct viral effects reduce blood flow to the kidneys, impairing their ability to filter waste products.

The adrenal glands, which regulate blood pressure through hormone production, may also become damaged. As hormone levels fall, maintaining normal blood pressure becomes increasingly difficult. Meanwhile, widespread inflammation causes blood vessels to leak fluid into surrounding tissues. Blood pressure drops.

Organs receive less oxygen. Cells begin dying. Eventually, the body enters multi-organ failure, the stage responsible for many Ebola-related deaths. Ironically, the virus itself is not destroying every organ directly. Much of the damage results from the combination of uncontrolled viral replication and an overwhelming immune response.

Why Can Survivors Carry Ebola for Months?

One of Ebola’s most surprising characteristics is that recovery does not always mean the virus has completely disappeared. Scientists once believed that patients who survived had eliminated the virus entirely. Research following the large West African outbreak between 2014 and 2016 changed that understanding. Doctors discovered that Ebola virus can sometimes remain in immune-privileged sites, areas of the body where immune surveillance is naturally limited to prevent excessive inflammation.

These include:

• The eyes
• The testes
• The central nervous system
• Occasionally the placenta during pregnancy

In some male survivors, viral genetic material has been detected in semen for many months after recovery, and in rare cases infectious virus has persisted long enough to result in sexual transmission. Some survivors also develop lingering health problems known as Post-Ebola Syndrome, which may include:

• Joint pain
• Muscle weakness
• Vision problems
• Chronic fatigue
• Headaches
• Psychological distress

Researchers are still investigating why some people experience long-term symptoms while others recover fully.

---

🧠 ScienceBuzzer Insight

Surviving Ebola is often the beginning of a new medical journey.

Many survivors require months or even years of follow-up care. Scientists continue studying how persistent virus and immune changes contribute to long-term health effects, hoping these discoveries will improve care for future survivors.

---

Why Doesn’t Ebola Become a Global Pandemic Like COVID-19?

This is one of the most frequently asked questions whenever Ebola makes headlines. The answer lies in how the virus spreads. Unlike SARS-CoV-2, the virus responsible for COVID-19, Ebola is not transmitted through the air during normal daily activities. Instead, infection usually requires direct contact with the blood or other body fluids of an infected person or contaminated objects such as needles and medical equipment.

People infected with Ebola also do not spread the virus before symptoms appear. Transmission becomes much more likely only after patients develop fever, vomiting, diarrhea, or other signs of illness, making it easier to identify cases and isolate them. In contrast, respiratory viruses like influenza and COVID-19 can spread through droplets and aerosols, sometimes even before infected individuals realize they are sick. That difference gives public health authorities a critical advantage. Rapid diagnosis, isolation of patients, contact tracing, safe burials, and community education have repeatedly brought Ebola outbreaks under control despite the virus’s high fatality rate.

Ebola vs COVID-19: Why They Behave So Differently

Feature	Ebola	COVID-19
Virus family	Filoviridae	Coronaviridae
Main route of transmission	Direct contact with infected body fluids	Respiratory droplets and aerosols
Spread before symptoms	Rare	Common
Typical incubation period	2–21 days	2–14 days
Average fatality rate	Much higher, varying by species and outbreak	Much lower overall
Pandemic potential	Generally limited	Very high

Although Ebola is far more deadly on an individual level, COVID-19 spread much more efficiently because infected people could unknowingly transmit the virus through the air before developing symptoms.

Why Are Scientists Still Struggling to Stop Ebola?

Over the past decade, remarkable progress has been made.

Highly effective vaccines now exist against the Zaire ebolavirus, the species responsible for several major outbreaks. Monoclonal antibody therapies have also significantly improved survival when administered early.

Yet important challenges remain.

Different Ebola species are genetically distinct. A vaccine that works well against one species may offer limited protection against another.

This is particularly relevant during outbreaks caused by the Bundibugyo or Sudan viruses, where no broadly licensed vaccines are currently available.

Scientists are now pursuing a new goal: developing pan-ebolavirus vaccines capable of protecting against multiple Ebola species with a single immunization.

Researchers are also studying antiviral drugs, improved antibody treatments, and rapid diagnostic tests that could detect infection earlier, when treatment is most effective.

At the same time, preventing outbreaks requires more than medical advances. Strengthening healthcare systems, improving disease surveillance, reducing misinformation, and working closely with affected communities remain essential components of Ebola control.

---

Key Takeaways

• Ebola is deadly because it attacks immune cells, disrupts blood vessels, and triggers overwhelming inflammation.
• Severe bleeding is not present in every patient and is often not the primary cause of death.
• Multi-organ failure results from both viral infection and the body’s excessive immune response.
• Some survivors can carry the virus in immune-privileged tissues for months after recovery.
• Ebola spreads through direct contact with infected body fluids, making it less transmissible than airborne respiratory viruses.
• Vaccines and antibody therapies have transformed Ebola care, but important scientific challenges remain for several Ebola virus species.

---

Conclusion

Few viruses inspire as much fear as Ebola, yet understanding its biology replaces fear with knowledge.

Ebola is not simply a “bleeding disease.” It is a master of immune evasion, capable of hijacking the body’s first line of defense, silencing critical antiviral signals, and triggering an inflammatory cascade that can damage nearly every organ. Its ability to persist in certain tissues after recovery reminds us that infectious diseases do not always end when symptoms disappear.

At the same time, Ebola is not an unstoppable virus. Advances in vaccines, antibody therapies, supportive medical care, and outbreak surveillance have dramatically improved our ability to save lives and contain epidemics. Every outbreak also teaches scientists something new about viral evolution, immune responses, and the remarkable resilience of the human body.

Understanding why Ebola is so deadly is more than an academic exercise. It reveals how viruses exploit biology, how our immune system fights back, and why science remains our most powerful tool in protecting global health.

References

1. World Health Organization (WHO). Ebola virus disease.
   https://www.who.int/news-room/fact-sheets/detail/ebola-virus-disease
2. World Health Organization. Disease Outbreak News: Ebola disease caused by Bundibugyo virus.
   https://www.who.int/emergencies/disease-outbreak-news
3. Centers for Disease Control and Prevention (CDC). About Ebola Disease.
   https://www.cdc.gov/ebola/about/index.html
4. National Institute of Allergy and Infectious Diseases (NIAID). Ebola.
   https://www.niaid.nih.gov/diseases-conditions/ebola